All News

The study, published in the journal Cancer, found that non-biological factors are as important as biological variables in shaping outcomes in young patients with leukemia.

Supporters say the bill would bring choice and dignity to those suffering, while opponents say the poor will be pressured by family members and heirs to take their lives because healthcare is too expensive.

Regulatory filings with the FDA are expected before the end of the year.

Unaccounted for social and clinical characteristics of a hospital's patient population explain nearly half of the difference in readmission rates between the best and the worst performing hospitals when it comes to Medicare penalties for hospital readmission rates.

Healthcare policy experts gathered in Washington, DC, to discuss access, cost, and the definition of value in oncology care.

The American public's perennially low opinion of the pharmaceutical industry has gotten even lower, and it seems unlikely that public opinion will gain much ground over the next year.

People with insurance have significantly higher probabilities of being diagnosed for diabetes, hypercholesterolemia, and hypertension than people without insurance.

The top stories in managed care this week include value-based pricing of the new PCSK9 inhibitors, CMS unveiled a new health equity plan for Medicare, and the American Medical Association released analyses on proposed health insurance mergers.

Democratic president hopeful Bernie Sanders took aim at the pharmaceutical industry with a new bill that would provide the government with negotiating power, allow the import of lower-cost drugs from Canada, and requires reporting of information that affects drug pricing.

CVS Health says narrow networks improve medication adherence in patients with chronic diseases.

An abstract presented at the 16th World Conference on Lung Cancer presented results from a study that monitored irAEs resulting from treatment with immune checkpoint inhibitors.

Avoidable risk factors to health are taking a growing toll on global health, according to an analysis of 79 risks in 188 countries. The results were published in The Lancet.

Treatment for high blood pressure should be more aggressive with a target lower than commonly recommended by guidelines, according to a study from the National Institutes of Health.

Although a new report from The Commonwealth Fund raised concerns about the competition of Medicare Advantage (MA) programs available across the country, a new analysis from Avalere Health found that there has been a growing number of MA plan options for consumers.

As CMS pushes healthcare systems to move away from fee-for-service, the state's largest insurer makes a major move toward value-based payment.

Presented at the ongoing World Conference on Lung Cancer, the trial has identified 7 actionable genomic alterations in lung cancer patients under 40 years of age.

House Republicans won a minor victory in a new lawsuit against the Obama administration for the legality of spending money from the Treasury for health insurers under the Affordable Care Act. Arguments will be heard this fall.

A draft report on the value-based price benchmark for the newly approved PCSK9 inhibitors for lowering bad cholesterol found that Repatha and Praluent should cost approximately 85% less than their list prices.

At the end of CMS' comment period, the American Society of Clinical Oncology submitted its comments and recommendations for the proposed changes.

Over 10 million personal records of Excellus BlueCross BlueShield customers were jeopardized when hackers gained access to the health plan's database.

The California Public Employees' Retirement System saved $7 million on screening colonoscopies during a 2-year period following implementation of reference pricing.

Research shows that about 150 minutes per week of moderate exercise, such as walking, can have significant health benefits. Changes in American lifestyles in recent decades have made limited the amount of time spent walking, with unfortunate results.

Despite concerns, consumer-driven health plans do not cause vulnerable populations to avoid care, but there are still opportunities for them to use their plans more wisely, according to a Cigna study.

The drug, approved in Japan last year, had been granted Breakthrough Therapy designation by the FDA.

CMS has released a new plan to address health equity in Medicare, which includes 6 priority areas aimed at reducing health disparities over the next 4 years.

Parents and advocates for a slower timetable pointed to existing issues within Medi-Cal as proof that the most vulnerable should not be rushed into managed care. But other states are moving ahead with plans.

With a new dosing schedule, low toxicity and a PD-L1 expression-driven response was observed.

Exercise is still recommended for those who are overweight, but the study suggests a vitamin C supplement can help those patients who can't or won't pursue activity.

Analyses from the American Medical Association determined the potential Aetna-Humana and Anthem-Cigna mergers will diminish competition in at least 23 states and more than 100 metropolitan areas.

With the comment period ending today, the proposed CMS cuts to radiation oncology reimbursement rates might have a substantial impact on community treatment centers.